Braskem updates on Novonor stake sale talks
Braskem S.A. reports that its shareholder Novonor S.A., which is undergoing judicial reorganization, continues to discuss the potential divestment of its stake in Braskem with Petroquímica Verde Fundo de Investimentos.
Rhea-AI Filing Summary
Braskem S.A. reports that its shareholder Novonor S.A., which is undergoing judicial reorganization, continues to discuss the potential divestment of its stake in Braskem with Petroquímica Verde Fundo de Investimentos. Novonor had received a proposal from this investment fund on May 23, 2025, with a 90-day exclusivity period for negotiating terms and conditions. Braskem states that this exclusivity has expired, but Novonor remains in talks with the fund about selling its interest in the company. Braskem commits to keeping shareholders and the market informed about any relevant developments related to this possible transaction.
Positive
- None.
Negative
- None.
Insights
Key shareholder keeps negotiating stake sale after exclusivity lapses.
Braskem discloses that Novonor, a major shareholder in judicial reorganization, is still in discussions with Petroquímica Verde Fundo de Investimentos about divesting its stake. The prior 90-day exclusivity tied to a May 23, 2025 proposal has ended, yet talks continue, indicating ongoing interest but no agreed terms.
For investors, the potential sale of Novonor’s stake could eventually affect Braskem’s ownership structure and possibly governance, depending on who becomes the new holder of that position. However, the disclosure does not describe transaction size, pricing, or likelihood of completion, only that discussions remain active.
The company notes it will keep the market informed of relevant developments, so future communications about any concrete agreement, conditions, or regulatory steps would clarify how this prospective divestment might reshape Braskem’s shareholder base.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Braskem (BAK) disclose about Novonor’s stake in the company?
Who is the potential buyer of Novonor’s stake in Braskem (BAK)?
What happened to the 90-day exclusivity period mentioned by Braskem (BAK)?
Does Braskem (BAK) say a stake sale by Novonor is agreed or completed?
How will Braskem (BAK) keep investors updated on Novonor’s potential divestment?
How can investors contact Braskem (BAK) for more information on this matter?
AI-generated analysis. How Rhea-AI works. Not financial advice.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of August, 2025
(Commission File No. 1-14862 )
BRASKEM S.A.
(Exact Name as Specified in its Charter)
N/A
(Translation of registrant's name into English)
Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ___X___ Form 40-F ______
Indicate by check mark if the registrant is
submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____
Indicate by check mark if the registrant is
submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____
Indicate by check mark whether the
registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ______ No ___X___
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.
BRASKEM S.A.
Corporate Taxpayer ID (CNPJ): 42.150.391/0001-70
Company Registry: 29.300.006.939
Publicly Held Company
MATERIAL FACT
Braskem S.A. (“Braskem” or the “Company”) (Ticker B3: BRKM3, BRKM5, and BRKM6; NYSE: BAK; LATIBEX: XBRK), hereby informs its shareholders and the market in general that has received, on this date, information from Novonor S.A. – Em Recuperação Judicial (“Novonor”) regarding the process of divestment of its stake in the Company, as follows:
“Dear Sirs,
We refer to the proposal received from Petroquímica Verde Fundo de Investimentos (“Fund”) on May 23, 2025 (“Proposal”), to inform you that, notwithstanding the expiration of the 90-day exclusivity period for negotiating the terms and conditions of said Proposal, Novonor remains in discussions with the Fund regarding the divestment of its stake.
We remain at your disposal.”
Braskem will keep the market informed of any relevant developments on the matter, in compliance with applicable laws and regulations.
Additional information can be obtained from the Investor Relations Department by phone at +55 (11) 3576-9531 or by e-mail braskem-ri@braskem.com.br.
São Paulo, August 22, 2025.
Felipe Montoro Jens
Chief Financial and Investor Relations Officer
Braskem S.A.
| 1 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: August 22, 2025
| BRASKEM S.A. | |||
| By: | /s/ Felipe Montoro Jens | ||
| Name: | Felipe Montoro Jens | ||
| Title: | Chief Financial Officer | ||
FORWARD-LOOKING STATEMENTS
This Material Fact may contain forward-looking statements. These statements are not historical facts, but rather are based on the current view and estimates of the Company's management regarding future economic and other circumstances, industry conditions, financial performance and results, including any potential or projected impact regarding the geological event in Alagoas and related legal procedures on the Company's business, financial condition and operating results. The words “project,” “believe,” “estimate,” “expect,” “plan”, “objective” and other similar expressions, when referring to the Company, are used to identify forward-looking statements. Statements related to the possible outcome of legal and administrative proceedings, implementation of operational and financing strategies and investment plans, guidance on future operations, the objective of expanding its efforts to achieve the sustainable macro objectives disclosed by the Company, as well as factors or trends that affect the financial condition, liquidity or operating results of the Company are examples of forward-looking statements. Such statements reflect the current views of the Company's management and are subject to various risks and uncertainties, many of which are beyond the Company’s control. There is no guarantee that the events, trends or expected results will actually occur. The statements are based on various assumptions and factors, including, but not limited to, general economic and market conditions, industry conditions and operating factors, availability, development and financial access to new technologies. Any change in these assumptions or factors, including the projected impact from the joint venture and its development of technologies, from the geological event in Alagoas and related legal procedures and the unprecedented impact on businesses, employees, service providers, shareholders, investors and other stakeholders of the Company could cause effective results to differ significantly from current expectations. For a comprehensive description of the risks and other factors that could impact any forward-looking statements in this document, especially the factors discussed in the sections, see the reports filed with the Brazilian Securities and Exchange Commission (CVM). This Material Fact does not constitute any offer of securities for sale in Brazil. No securities may be offered or sold in Brazil without being registered or exempted from registration, and any public offer of securities carried out in Brazil must be made through a prospectus, which would be made available by Braskem and contain detailed information on Braskem and its management, as well as its financial statements.